Compass Therapeutics, Inc.
CMPX
$1.97
$0.105.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 194.69M | 208.91M | 219.90M | 100.95M | 112.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.00M | 913.00K | 1.23M | 5.25M | 11.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 195.69M | 209.82M | 221.12M | 106.20M | 124.15M |
|
|
|||||
| Total Current Assets | 195.69M | 209.82M | 221.12M | 106.20M | 124.15M |
| Net Property, Plant & Equipment | 8.92M | 9.20M | 9.57M | 9.94M | 6.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 568.00K | 568.00K | 568.00K | 568.00K | 568.00K |
| Total Assets | 205.17M | 219.59M | 231.26M | 116.70M | 131.45M |
|
|
|||||
| Total Accounts Payable | 906.00K | 1.59M | 3.10M | 2.60M | 1.58M |
| Total Accrued Expenses | 8.00M | 11.38M | 8.68M | 10.99M | 13.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.37M | 1.00M | 633.00K | 271.00K | 109.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.28M | 13.97M | 12.41M | 13.86M | 14.90M |
|
|
|||||
| Total Current Liabilities | 10.28M | 13.97M | 12.41M | 13.86M | 14.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.42M | 8.83M | 9.23M | 9.63M | 6.27M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.70M | 22.80M | 21.65M | 23.49M | 21.17M |
|
|
|||||
| Common Stock & APIC | 636.12M | 627.68M | 624.80M | 494.20M | 491.41M |
| Retained Earnings | -449.49M | -431.17M | -415.46M | -401.20M | -381.32M |
| Treasury Stock & Other | -159.00K | 280.00K | 274.00K | 208.00K | 190.00K |
| Total Common Equity | 186.47M | 196.79M | 209.61M | 93.21M | 110.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 186.47M | 196.79M | 209.61M | 93.21M | 110.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 186.47M | 196.79M | 209.61M | 93.21M | 110.28M |
|
|
|||||